Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Dupixent (dupilumab) Disease area(s): Immunology/respiratory Manufacturer(s): Sanofi/Regeneron 2024 Sales (USD): $14.15 billion Why it sold so well: Co-developed by Sanofi and Regeneron, Dupixent achieved significant success in 2024, with global net sales reaching $14.15 billion a 22% increase over 2023
N-acetylcysteine (NAC), a bioavailable cysteine donor, can support endogenous GSH synthesis and may also exert antioxidant effects independent of GSH replenishment
Book online in Austin
The peptide maintains endothelial integrity to ensure proper blood flow to the mucosa while directly stimulating cellular repair processes
US$ 25.15
US$ 26.92
/i.s3.glbimg.com/v1/AUTH_59edd422c0c84a879bd37670ae4f538a/internal_photos/bs/2026/M/j/zJ76gJSXWI4N9lA9iVGg/41a4c39f-382b-46a3-8b81-a7a2e596fa3e.webp)
US$ 27.08
US$ 29.88
